Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

β-Catenin-dependent lysosomal targeting of internalized tumor necrosis factor-α suppresses caspase-8 activation in apoptosis-resistant colon cancer cells.

Han J, Sridevi P, Ramirez M, Ludwig KJ, Wang JY.

Mol Biol Cell. 2013 Feb;24(4):465-73. doi: 10.1091/mbc.E12-09-0662. Epub 2012 Dec 21.

2.

Nuclear expression of β-catenin promotes RB stability and resistance to TNF-induced apoptosis in colon cancer cells.

Han J, Soletti RC, Sadarangani A, Sridevi P, Ramirez ME, Eckmann L, Borges HL, Wang JY.

Mol Cancer Res. 2013 Mar;11(3):207-18. doi: 10.1158/1541-7786.MCR-12-0670. Epub 2013 Jan 21.

3.

Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.

Horova V, Hradilova N, Jelinkova I, Koc M, Svadlenka J, Brazina J, Klima M, Slavik J, Hyrslova Vaculova A, Andera L.

FEBS J. 2013 Jul;280(14):3436-50. doi: 10.1111/febs.12347. Epub 2013 Jun 18.

4.

Caspase-mediated cleavage of beta-catenin precedes drug-induced apoptosis in resistant cancer cells.

Senthivinayagam S, Mishra P, Paramasivam SK, Yallapragada S, Chatterjee M, Wong L, Rana A, Rana B.

J Biol Chem. 2009 May 15;284(20):13577-88. doi: 10.1074/jbc.M900248200. Epub 2009 Mar 16.

5.

Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin.

Lee SY, Lim TG, Chen H, Jung SK, Lee HJ, Lee MH, Kim DJ, Shin A, Lee KW, Bode AM, Surh YJ, Dong Z.

Cancer Prev Res (Phila). 2013 Dec;6(12):1356-64. doi: 10.1158/1940-6207.CAPR-13-0241. Epub 2013 Oct 8.

6.

IL-32γ enhances TNF-α-induced cell death in colon cancer.

Park ES, Yoo JM, Yoo HS, Yoon DY, Yun YP, Hong J.

Mol Carcinog. 2014 Feb;53 Suppl 1:E23-35. doi: 10.1002/mc.21990. Epub 2012 Dec 19.

PMID:
23255489
7.

Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells.

Hsu HH, Cheng SF, Chen LM, Liu JY, Chu CH, Weng YJ, Li ZY, Lin CS, Lee SD, Kuo WW, Huang CY.

Mol Cell Biochem. 2006 Sep;289(1-2):101-9. Epub 2006 Apr 21.

PMID:
16628468
8.
9.

OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.

De Toni EN, Thieme SE, Herbst A, Behrens A, Stieber P, Jung A, Blum H, Göke B, Kolligs FT.

Clin Cancer Res. 2008 Aug 1;14(15):4713-8. doi: 10.1158/1078-0432.CCR-07-5019.

10.

Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.

Lee MA, Park HJ, Chung HJ, Kim WK, Lee SK.

J Nat Prod. 2013 Jul 26;76(7):1278-84. doi: 10.1021/np400216m. Epub 2013 Jul 15.

PMID:
23855266
11.

Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.

He SB, Yuan Y, Wang L, Yu MJ, Zhu YB, Zhu XG.

J Exp Clin Cancer Res. 2011 Nov 22;30:109. doi: 10.1186/1756-9966-30-109.

12.

Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.

Wang S, Bao Z, Liang QM, Long JW, Xiao ZS, Jiang ZJ, Liu B, Yang J, Long ZX.

Hepatogastroenterology. 2013 Oct;60(127):1639-46.

PMID:
24634935
13.

Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.

Luna-Ulloa LB, Hernández-Maqueda JG, Santoyo-Ramos P, Castañeda-Patlán MC, Robles-Flores M.

Carcinogenesis. 2011 Nov;32(11):1615-24. doi: 10.1093/carcin/bgr190. Epub 2011 Aug 22.

14.

Inhibition of β-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation.

Kabátková M, Zapletal O, Tylichová Z, Neča J, Machala M, Milcová A, Topinka J, Kozubík A, Vondráček J.

Mutagenesis. 2015 Jul;30(4):565-76. doi: 10.1093/mutage/gev019. Epub 2015 Mar 24.

15.

β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells.

Keerthivasan S, Aghajani K, Dose M, Molinero L, Khan MW, Venkateswaran V, Weber C, Emmanuel AO, Sun T, Bentrem DJ, Mulcahy M, Keshavarzian A, Ramos EM, Blatner N, Khazaie K, Gounari F.

Sci Transl Med. 2014 Feb 26;6(225):225ra28. doi: 10.1126/scitranslmed.3007607.

16.

Growth inhibition effect of β-catenin small interfering RNA-mediated gene silencing on human colon carcinoma HT-29 cells.

Xu WL, Wang Q, Du M, Zhao YH, Sun XR, Sun WG, Chen BQ.

Cancer Biother Radiopharm. 2010 Oct;25(5):529-37. doi: 10.1089/cbr.2010.0768.

PMID:
20950152
17.

Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice.

Li TW, Yang H, Peng H, Xia M, Mato JM, Lu SC.

Carcinogenesis. 2012 Feb;33(2):427-35. doi: 10.1093/carcin/bgr295. Epub 2011 Dec 9.

18.

Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.

Larriba MJ, Ordóñez-Morán P, Chicote I, Martín-Fernández G, Puig I, Muñoz A, Pálmer HG.

PLoS One. 2011;6(8):e23524. doi: 10.1371/journal.pone.0023524. Epub 2011 Aug 15.

19.

Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.

Wu K, Yang Q, Mu Y, Zhou L, Liu Y, Zhou Q, He B.

Int J Oncol. 2012 Jul;41(1):292-8. doi: 10.3892/ijo.2012.1423. Epub 2012 Apr 2.

PMID:
22469784
20.

ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.

Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.

Gastroenterology. 2014 Aug;147(2):430-442.e8. doi: 10.1053/j.gastro.2014.04.047. Epub 2014 May 15.

PMID:
24846398
Items per page

Supplemental Content

Write to the Help Desk